1,2-dichloroethane increases expression ISO Bcl11a (Mus musculus) 6480464 ethylene dichloride results in increased expression of BCL11A mRNA CTD PMID:28960355 1,2-dimethylhydrazine multiple interactions ISO Bcl11a (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of BCL11A mRNA CTD PMID:22206623 1,3-dinitrobenzene decreases expression EXP 6480464 3-dinitrobenzene results in decreased expression of BCL11A mRNA CTD PMID:21983209 17alpha-ethynylestradiol multiple interactions ISO Bcl11a (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of BCL11A mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO BCL11A (Homo sapiens) 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of BCL11A mRNA CTD PMID:20660070 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Bcl11a (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of BCL11A mRNA CTD PMID:15652763 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Bcl11a (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of BCL11A mRNA CTD PMID:17942748 2,4-dibromophenyl 2,4,5-tribromophenyl ether decreases expression ISO BCL11A (Homo sapiens) 6480464 2 more ... CTD PMID:26705709 2-methoxyethanol decreases expression EXP 6480464 methyl cellosolve results in decreased expression of BCL11A mRNA CTD PMID:21061450 2-methylcholine affects expression ISO BCL11A (Homo sapiens) 6480464 beta-methylcholine affects the expression of BCL11A mRNA CTD PMID:21179406 3,4-methylenedioxymethamphetamine increases methylation ISO Bcl11a (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased methylation of BCL11A promoter CTD PMID:26251327 3,4-methylenedioxymethamphetamine decreases expression ISO Bcl11a (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of BCL11A mRNA CTD PMID:26251327 4,4'-sulfonyldiphenol increases expression ISO BCL11A (Homo sapiens) 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of BCL11A mRNA CTD PMID:25912373 acrylamide decreases expression ISO BCL11A (Homo sapiens) 6480464 Acrylamide results in decreased expression of BCL11A mRNA CTD PMID:32763439 aflatoxin B1 increases methylation ISO BCL11A (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of BCL11A intron CTD PMID:30157460 Aflatoxin B2 alpha increases methylation ISO BCL11A (Homo sapiens) 6480464 aflatoxin B2 results in increased methylation of BCL11A intron CTD PMID:30157460 aldehydo-D-glucose multiple interactions ISO Bcl11a (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with glyphosate] results in decreased expression of BCL11A mRNA CTD PMID:37567420 all-trans-retinoic acid decreases expression ISO BCL11A (Homo sapiens) 6480464 Tretinoin results in decreased expression of BCL11A mRNA CTD PMID:15498508 and PMID:33167477 amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of BCL11A mRNA CTD PMID:30779732 antirheumatic drug decreases expression ISO BCL11A (Homo sapiens) 6480464 Antirheumatic Agents results in decreased expression of BCL11A mRNA CTD PMID:24449571 arsane affects methylation ISO BCL11A (Homo sapiens) 6480464 Arsenic affects the methylation of BCL11A gene CTD PMID:25304211 arsenic atom affects methylation ISO BCL11A (Homo sapiens) 6480464 Arsenic affects the methylation of BCL11A gene CTD PMID:25304211 belinostat increases expression ISO BCL11A (Homo sapiens) 6480464 belinostat results in increased expression of BCL11A mRNA CTD PMID:26272509 belinostat multiple interactions ISO BCL11A (Homo sapiens) 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BCL11A mRNA CTD PMID:27188386 benzo[a]pyrene decreases expression ISO Bcl11a (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of BCL11A mRNA CTD PMID:21569818 benzo[a]pyrene affects methylation ISO BCL11A (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of BCL11A exon CTD PMID:27901495 benzo[a]pyrene decreases expression ISO BCL11A (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of BCL11A mRNA CTD PMID:20064835 bis(2-ethylhexyl) phthalate increases expression ISO BCL11A (Homo sapiens) 6480464 Diethylhexyl Phthalate results in increased expression of BCL11A mRNA CTD PMID:31163220 bisphenol A decreases expression ISO BCL11A (Homo sapiens) 6480464 bisphenol A results in decreased expression of BCL11A mRNA CTD PMID:22576693 bisphenol A decreases expression ISO Bcl11a (Mus musculus) 6480464 bisphenol A results in decreased expression of BCL11A mRNA CTD PMID:32156529 bisphenol A multiple interactions ISO BCL11A (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of BCL11A gene CTD PMID:31601247 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of BCL11A gene CTD PMID:28505145 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of BCL11A mRNA CTD PMID:25181051 buta-1,3-diene decreases expression ISO Bcl11a (Mus musculus) 6480464 1 and 3-butadiene results in decreased expression of BCL11A mRNA CTD PMID:29038090 butanal increases expression ISO BCL11A (Homo sapiens) 6480464 butyraldehyde results in increased expression of BCL11A mRNA CTD PMID:26079696 carbon nanotube increases expression ISO Bcl11a (Mus musculus) 6480464 Nanotubes and Carbon results in increased expression of BCL11A mRNA CTD PMID:25554681 casticin decreases expression ISO Bcl11a (Mus musculus) 6480464 casticin results in decreased expression of BCL11A mRNA CTD PMID:28444820 CGP 52608 multiple interactions ISO BCL11A (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to BCL11A gene] CTD PMID:28238834 chloroprene decreases expression ISO Bcl11a (Mus musculus) 6480464 Chloroprene results in decreased expression of BCL11A mRNA CTD PMID:23125180 choline multiple interactions ISO Bcl11a (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of BCL11A gene CTD PMID:20938992 chrysene increases expression ISO Bcl11a (Mus musculus) 6480464 chrysene results in increased expression of BCL11A mRNA CTD PMID:26377693 cobalt dichloride decreases expression ISO Bcl11a (Mus musculus) 6480464 cobaltous chloride results in decreased expression of BCL11A mRNA CTD PMID:21139344 copper atom multiple interactions ISO BCL11A (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in decreased expression of BCL11A mRNA CTD PMID:20971185 copper(0) multiple interactions ISO BCL11A (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in decreased expression of BCL11A mRNA CTD PMID:20971185 D-glucose multiple interactions ISO Bcl11a (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with glyphosate] results in decreased expression of BCL11A mRNA CTD PMID:37567420 dichloroacetic acid increases expression ISO Bcl11a (Mus musculus) 6480464 Dichloroacetic Acid results in increased expression of BCL11A mRNA CTD PMID:28962523 dioxygen multiple interactions ISO Bcl11a (Mus musculus) 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BCL11A mRNA CTD PMID:30529165 diuron decreases expression EXP 6480464 Diuron results in decreased expression of BCL11A mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO BCL11A (Homo sapiens) 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 elemental selenium decreases expression ISO BCL11A (Homo sapiens) 6480464 Selenium results in decreased expression of BCL11A mRNA CTD PMID:19244175 entinostat multiple interactions ISO BCL11A (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BCL11A mRNA CTD PMID:27188386 entinostat increases expression ISO BCL11A (Homo sapiens) 6480464 entinostat results in increased expression of BCL11A mRNA CTD PMID:26272509 ethanol affects splicing ISO Bcl11a (Mus musculus) 6480464 Ethanol affects the splicing of BCL11A mRNA CTD PMID:30319688 folic acid multiple interactions ISO Bcl11a (Mus musculus) 6480464 [1 more ... CTD PMID:20938992 and PMID:22206623 formaldehyde decreases expression ISO BCL11A (Homo sapiens) 6480464 Formaldehyde results in decreased expression of BCL11A mRNA CTD PMID:20655997 and PMID:27664576 fructose multiple interactions ISO Bcl11a (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with glyphosate] results in decreased expression of BCL11A mRNA CTD PMID:37567420 fulvestrant increases methylation ISO BCL11A (Homo sapiens) 6480464 Fulvestrant results in increased methylation of BCL11A gene CTD PMID:31601247 fulvestrant multiple interactions ISO BCL11A (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of BCL11A gene CTD PMID:31601247 geraniol decreases expression ISO BCL11A (Homo sapiens) 6480464 geraniol results in decreased expression of BCL11A mRNA CTD PMID:27683099 glucose multiple interactions ISO Bcl11a (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with glyphosate] results in decreased expression of BCL11A mRNA CTD PMID:37567420 glyphosate multiple interactions ISO Bcl11a (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with glyphosate] results in decreased expression of BCL11A mRNA CTD PMID:37567420 hydroquinone decreases expression ISO BCL11A (Homo sapiens) 6480464 hydroquinone results in decreased expression of BCL11A mRNA CTD PMID:31256213 L-methionine multiple interactions ISO Bcl11a (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of BCL11A gene CTD PMID:20938992 lipopolysaccharide multiple interactions ISO BCL11A (Homo sapiens) 6480464 S-(1 and 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of BCL11A mRNA] CTD PMID:35811015 lipopolysaccharide increases expression ISO BCL11A (Homo sapiens) 6480464 Lipopolysaccharides results in increased expression of BCL11A mRNA CTD PMID:35811015 maneb multiple interactions ISO Bcl11a (Mus musculus) 6480464 [Maneb co-treated with Paraquat] results in decreased expression of BCL11A mRNA CTD PMID:36117858 mercury dibromide increases expression ISO BCL11A (Homo sapiens) 6480464 mercuric bromide results in increased expression of BCL11A mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO BCL11A (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BCL11A mRNA CTD PMID:27188386 methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of BCL11A gene CTD PMID:35440735 methylmercury chloride increases expression ISO BCL11A (Homo sapiens) 6480464 methylmercuric chloride results in increased expression of BCL11A mRNA CTD PMID:28001369 nickel atom decreases expression ISO BCL11A (Homo sapiens) 6480464 Nickel results in decreased expression of BCL11A mRNA CTD PMID:24768652 nickel sulfate decreases expression ISO BCL11A (Homo sapiens) 6480464 nickel sulfate results in decreased expression of BCL11A mRNA CTD PMID:18651567 oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of BCL11A mRNA CTD PMID:25729387 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of BCL11A mRNA CTD PMID:25729387 ozone multiple interactions ISO Bcl11a (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of BCL11A mRNA CTD PMID:34911549 panobinostat multiple interactions ISO BCL11A (Homo sapiens) 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BCL11A mRNA CTD PMID:27188386 panobinostat increases expression ISO BCL11A (Homo sapiens) 6480464 panobinostat results in increased expression of BCL11A mRNA CTD PMID:26272509 paracetamol affects expression ISO Bcl11a (Mus musculus) 6480464 Acetaminophen affects the expression of BCL11A mRNA CTD PMID:17562736 paracetamol increases expression ISO BCL11A (Homo sapiens) 6480464 Acetaminophen results in increased expression of BCL11A mRNA CTD PMID:26690555 paraquat multiple interactions ISO Bcl11a (Mus musculus) 6480464 [Maneb co-treated with Paraquat] results in decreased expression of BCL11A mRNA CTD PMID:36117858 pentanal increases expression ISO BCL11A (Homo sapiens) 6480464 pentanal results in increased expression of BCL11A mRNA CTD PMID:26079696 phenylmercury acetate increases expression ISO BCL11A (Homo sapiens) 6480464 Phenylmercuric Acetate results in increased expression of BCL11A mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO BCL11A (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BCL11A mRNA CTD PMID:27188386 pioglitazone decreases expression ISO BCL11A (Homo sapiens) 6480464 Pioglitazone results in decreased expression of BCL11A mRNA CTD PMID:30031879 progesterone multiple interactions ISO BCL11A (Homo sapiens) 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of BCL11A mRNA CTD PMID:20660070 propanal increases expression ISO BCL11A (Homo sapiens) 6480464 propionaldehyde results in increased expression of BCL11A mRNA CTD PMID:26079696 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO BCL11A (Homo sapiens) 6480464 S-(1 and 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of BCL11A mRNA] CTD PMID:35811015 SB 431542 multiple interactions ISO BCL11A (Homo sapiens) 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 selenium atom decreases expression ISO BCL11A (Homo sapiens) 6480464 Selenium results in decreased expression of BCL11A mRNA CTD PMID:19244175 silicon dioxide decreases expression ISO BCL11A (Homo sapiens) 6480464 Silicon Dioxide results in decreased expression of BCL11A mRNA CTD PMID:25351596 sodium arsenite decreases expression ISO Bcl11a (Mus musculus) 6480464 sodium arsenite results in decreased expression of BCL11A mRNA CTD PMID:36209798 sunitinib decreases expression ISO BCL11A (Homo sapiens) 6480464 Sunitinib results in decreased expression of BCL11A mRNA CTD PMID:31533062 tamibarotene decreases expression ISO BCL11A (Homo sapiens) 6480464 tamibarotene results in decreased expression of BCL11A mRNA CTD PMID:15498508 temozolomide increases expression ISO BCL11A (Homo sapiens) 6480464 Temozolomide results in increased expression of BCL11A mRNA CTD PMID:31758290 testosterone increases expression ISO Bcl11a (Mus musculus) 6480464 Testosterone deficiency results in increased expression of BCL11A mRNA CTD PMID:33848595 testosterone multiple interactions ISO Bcl11a (Mus musculus) 6480464 1 more ... CTD PMID:33848595 titanium dioxide increases expression ISO Bcl11a (Mus musculus) 6480464 titanium dioxide results in increased expression of BCL11A mRNA CTD PMID:23557971 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of BCL11A mRNA CTD PMID:25729387 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of BCL11A mRNA CTD PMID:25729387 Tributyltin oxide increases expression ISO Bcl11a (Mus musculus) 6480464 bis(tri-n-butyltin)oxide results in increased expression of BCL11A mRNA CTD PMID:18958704 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of BCL11A mRNA CTD PMID:33387578 trichostatin A increases expression ISO BCL11A (Homo sapiens) 6480464 trichostatin A results in increased expression of BCL11A mRNA CTD PMID:24935251 and PMID:26272509 trichostatin A multiple interactions ISO BCL11A (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BCL11A mRNA CTD PMID:27188386 trimellitic anhydride increases expression ISO Bcl11a (Mus musculus) 6480464 trimellitic anhydride results in increased expression of BCL11A mRNA CTD PMID:19042947 tunicamycin increases expression ISO Bcl11a (Mus musculus) 6480464 Tunicamycin results in increased expression of BCL11A mRNA CTD PMID:17127020 valproic acid decreases expression ISO BCL11A (Homo sapiens) 6480464 Valproic Acid results in decreased expression of BCL11A mRNA CTD PMID:24935251 valproic acid increases expression ISO BCL11A (Homo sapiens) 6480464 Valproic Acid results in increased expression of BCL11A mRNA CTD PMID:19101580 more ... valproic acid multiple interactions ISO BCL11A (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BCL11A mRNA CTD PMID:27188386 vitamin E decreases expression ISO BCL11A (Homo sapiens) 6480464 Vitamin E results in decreased expression of BCL11A mRNA CTD PMID:19244175 vorinostat multiple interactions ISO BCL11A (Homo sapiens) 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BCL11A mRNA CTD PMID:27188386 vorinostat increases expression ISO BCL11A (Homo sapiens) 6480464 vorinostat results in increased expression of BCL11A mRNA CTD PMID:26272509